The evolution of mendelian randomization for investigating drug effects

dc.contributor.author	Gill, Dipender
dc.contributor.author	Burgess, Stephen
dc.date.accessioned	2022-02-03T20:05:59Z
dc.date.available	2022-02-03T20:05:59Z
dc.date.issued	2022-02-03
dc.identifier.issn	1549-1277
dc.identifier.other	pmedicine-d-21-05010
dc.identifier.uri	https://www.repository.cam.ac.uk/handle/1810/333608
dc.description.abstract	Dipender Gill and Stephen Burgess discuss the accompanying study by James Yarmolinsky and colleagues investigating the associations between genetically-proxied inhibition of antihypertensive drug targets and risk of common cancer subtypes using Mendelian randomization.
dc.language	en
dc.publisher	Public Library of Science
dc.subject	Perspective
dc.subject	Biology and life sciences
dc.subject	Medicine and health sciences
dc.title	The evolution of mendelian randomization for investigating drug effects
dc.type	Other
dc.date.updated	2022-02-03T20:05:58Z
prism.issueIdentifier	2
prism.publicationName	PLOS Medicine
prism.volume	19
dc.identifier.doi	10.17863/CAM.81024
rioxxterms.versionofrecord	10.1371/journal.pmed.1003898
rioxxterms.version	VoR
rioxxterms.licenseref.uri	http://creativecommons.org/licenses/by/4.0/
dc.contributor.orcid	Gill, Dipender [0000-0001-7312-7078]
dc.contributor.orcid	Burgess, Stephen [0000-0001-5365-8760]
dc.identifier.eissn	1549-1676

Jisc Publications Router
This collection holds Cambridge publications received from the Jisc Publications Router